𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sustained activity and release of leuprolide acetate from an in situ forming polymeric implant

✍ Scribed by Harish B. Ravivarapu; Katie L. Moyer; Richard L. Dunn

Book ID
111766978
Publisher
Springer US
Year
2000
Tongue
English
Weight
157 KB
Volume
1
Category
Article
ISSN
1530-9932

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Sustained suppression of pituitary-gonad
Sustained suppression of pituitary-gonadal axis with an injectable, in situ forming implant of leuprolide acetate
✍ Harish B. Ravivarapu; Katie L. Moyer; Richard L. Dunn πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 268 KB

The objective of these studies was to develop a leuprolide acetate depot based on an in situ forming drug delivery system (Atrigel(R)) to suppress the pituitary-gonadal axis and in turn the serum testosterone to chemical castration levels for a period of at least 3 months. Formulations with biodegra

Zinc–leuprolide complex: preparation, ph
Zinc–leuprolide complex: preparation, physicochemical characterization and release behaviour from in situ forming implant
✍ Reyhaneh Astaneh; Nastaran Nafissi-Varcheh; Mohammad Erfan πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 221 KB

## Abstract Leuprolide acetate (LA) has been accepted as treatment for prostatic cancer and is currently also being evaluated in phase II clinical trials for the treatment of Alzheimer's disease. In this study, the zinc complex of leuprolide was prepared and its structure determined by Fourier‐tran

Sucrose acetate isobutyrate as an In Sit
Sucrose acetate isobutyrate as an In Situ forming system for sustained risperidone release
✍ Yaxin Lu; Yeling Yu; Xing Tang πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 238 KB

The objective of this study was to develop sustained-release sucrose acetate isobutyrate (SAIB) in situ formulations of risperidone for parenteral delivery. The formulations contained SAIB, solvent (anhydrous ethanol, ethyl lactate, or N-methyl-2-pyrrolidone), and additives such as polylactic acid (